>>> US Gapping Up

Gapping up
In reaction to strong earnings/guidance
: INVT +34.1%, NEPT +14.3%, DRI +0.5%

M&A news: KUTV +14.9% (to be acquired by Shanda Investment Holdings in a going-private transaction valued at $1.08/ADR ), PFE +2.3% (US Treasury issues inversion regulations and proposed earnings stripping regulations)

Select metals/mining stocks trading higher: GFI +5.8%, HMY +4.5%, ABX +3%, GDX +2.5%, AU +2.1%, GG +2%,GOLD +1.5%, X +1.5%, SLV +1.4%, GLD +1.4%

Other news: CLIR +16% ( announced agreement with 'major Canadian oil sands producer' to design and engineer ClearSign's Duplex technology ), TWTR +4% (said to win deal to stream NFL Thursday Night games, according to Bloomberg), RH +2.7% (to replace Atmel Corp in the S&P MidCap 400 after the close of trading on April 6), STXS +1.8% (announced that multiple hospitals completed more than 1,000 cardiac ablation procedures using its Niobe remote magnetic navigation system)

Analyst comments: N/A

>>> US Gapping Down

Gapping down
In reaction to disappointing earnings/guidance
: NATI -8.4%, GBX -5.6%, CPST -1.4%, WBA -1.1%, NG -1%

M&A news: AGN -19.3% (US Treasury issues inversion regulations and proposed earnings stripping regulations), PE -3.3% (acquires two properties in Southern Delaware for $359 mln in cash; updates guidance; commences 16 mln Class A common stock offering)

Select EU financial related names showing weakness: RBS -3.7%, DB -3.3%, CS -3.3%, BCS -3.2%, HSBC -3.2%, LYG-2.8%, SAN -2.3%, PUK -2.2%

Select oil/gas related names showing early weakness: RDS.A -2.8%, STO -2.7%, SDRL -2.7%, BP -2.4%, TOT -2%

Other news: PSUN -28.4% (rumors of potential Chapter 11 filing), TM -3.8% (like down due to Yen strength), TSLA -3.5% (Q1 delvieries 14820, below 16K guidance ), DIS -2.1% ( confirms COO Thomas Staggs to elave the company effective May 6 ), VRX -2.1% (terminates its sales team for its female libido pill Addyi, according to Bloomberg), SE -1.9% (prices offering of 14 mln shares of its common stock at $30 per share), AKR -1.5% ( commences ~3.6 mln public offering of common shares)

Analyst comments: CSCO -2.1% (downgraded to Neutral from Buy at BofA/Merrill), HRL -2.1% (downgraded to Underweight from Hold at BB&T Capital Mkts), BABY -1.2% (downgraded to Mkt Perform from Outperform at Raymond James)

>>> US Early premarket gappers

Early premarket gappers

Gapping up: INVT +22%, CLIR +16%, STXS +15.2%, GFI +6.1%, CPST +5.6%, HMY+4.7%, GDX +3.1%, ABX +2.7%, PFE +2.6%, GG +2.5%, DRI +2.5%, SUNE +2.4%, RH+2.3%, RH +2.3%, SLW +2.2%, AU +2%, TWTR +1.8%, GOLD +1.6%, SLV +1.5%, GLD+1.4%, GBX +0.5%

Gapping down: PSUN -28.5%, AGN -20.7%, NATI -8.4%, DRWI -8.3%, TM -5.8%, MT-4.1%, TSLA -3.7%, BCS -3.3%, DB -3.3%, RBS -3.2%, CS -3.1%, BHP -3.1%, HSBC-3%, BBL -3%, LYG -2.8%, PUK -2.8%, RDS.A -2.7%, STO -2.7%, SDRL -2.7%, AKR-2.6%, SHPG -2.4%, RIO -2.3%, BP -2.3%, DIS -2.2%, VRX -2.2%, SAN -2.1%, TOT-2.1%, X -2.1%, CSCO -1.9%, SE -1.8%, PE -1.5%, NG -1%, WBA -0.7%

>>> Walt Disney: Color on COO departure

Walt Disney: Color on COO departure (98.69)

* FBR Capital, like everyone else, was surprised to see that Thomas Staggs is departing May 6 after looking like the heir apparent for CEO for the past year. This unexpected executive shuffle likely creates stress lines in the image of cool stability that has been the public veneer of Disney under current CEO Bob Iger. Clearly, that is a little concerning. Still, what matters is the end result. And Disney and Iger have two years left to figure this out and get Disney a new leader who can carry on in the successful track (particularly in movies) laid down by Iger.
* Topeka is very surprised by the departure of COO Tom Staggs and heir apparent CEO. They would surmise that in the near term, in order to assuage nervous investors, Mr. Iger likely extends his contract beyond 2018, and the DIS board will immediately gets to work on an extensive search for Mr. Iger's replacement. Names that likely make the short list are: 1. John Skipper, current heard of ESPN; 2. Anne Sweeney, ex-head of Media Networks, (now retired, but they wouldn't rule it out.); 3. Sheryl Sandberg, current Facebook (FB) COO; and 4. Ben Sherwood, current Media Networks co-chair.
--> DIS -2.3% premarket.

WSJ : In Oil, a Trader Stands Out by Surviving

In Oil, a Trader Stands Out by Surviving

Pierre Andurand’s fund has been one of only a handful to correctly call oil-price moves as many peers shut down

A day after oil prices plunged to a 13-year low in January, Pierre Andurand, a French hedge-fund manager who made millions betting against crude, started buying.

For the former Goldman Sachs energy trader, one of the last commodity hedge-fund traders left standing in an oil slump littered with casualties, it was the first bet on rising prices since 2014.

So far, his timing has proved correct. Despite investors’ widespread fears of a persistent crude glut, the price of international benchmark, Brent, has rallied close to 40% since Mr. Andurand’s call on Jan. 21.

“I started to have a lot of signals showing the market may be turning” from mid-December, Mr. Andurand, a kickboxing devotee with a reputation for aggressive trades, said in a recent interview at his firm’s London offices. In March, he predicted a “multiyear bull run,” according to a letter to investors reviewed by The Wall Street Journal.

Andurand Capital Management LLP, set up three years ago from the ashes of $2.4 billion hedge fund BlueGold Capital Management LP, has been one of only a handful of funds globally to correctly call moves in the price of oil since the summer of 2014, when crude began its marked slump.

Having bet against oil in September 2014, Mr. Andurand’s fledgling fund gained almost 60%—a profit of $160 million—in four months as the price of oil almost halved. Hedge funds on average gained 0.1% over that period, according to Hedge Fund Research. So far this year, Andurand’s $710 million fund is up 5.8%.

In contrast, the sharp downturn in commodity prices in recent years has left many mining and energy companies strapped for cash, forcing hedge funds run by firms including Clive Capital, Centaurus Capital and Brevan Howard to shut down.

Big names including Andrew Hall’s Astenbeck Capital notched big losses last year due to an overly bullish stance, while funds run by Brigade Capital Management and King Street Capital Management lost money after investing in oil firms’ debt too early last year.

Mr. Andurand started betting against oil in late September 2014 because he had become concerned about sluggish global oil demand and burgeoning supply from the U.S. and Libya.

Two months later, the Organization of the Petroleum Exporting Countries surprised the market by refusing to cut its output as it had in previous episodes of oversupply. The result of that meeting was “so clear a confirmation” of Mr. Andurand’s views that he raised his position.

“We had to increase relatively fast because we knew it would be a catalyst for a price move,” he said. However, memories of past losses kept his position below the maximum he could run.

“I had very high conviction level, but I got burned a few times a few years before, so I was still a little cautious,” said Mr. Andurand, whose BlueGold fund chalked up huge gains during the credit crisis before folding after large losses in 2011.

His new fund returned 38% in 2014, ranking it as one of the world’s top-performing hedge funds, thanks to the bet on falling oil prices.

Last year proved harder. Despite being correctly positioned—oil dropped 35% during 2015—Mr. Andurand was hit by sharp bear-market rallies, particularly in April. “The fundamental view was right, but it was difficult to generate really high returns from it” without risking big losses, he said.

It was sticking with the position, rather than the size of the bet, that made the money, he said. Last year’s more modest 4% return beat hedge funds’ average 1.1% loss, according to HFR.

Mr. Andurand’s decision to flip his bets and start buying this year was based on his view that prices have fallen enough to induce falling supply. Oil prices still are down close to 70% from the summer of 2014, pushed down by an oversupply of crude around the globe.

In recent weeks, oil prices also have been supported by hopes that major producers will agree to limit their output. Around a dozen oil-producing countries, including Saudi Arabia and Russia, will meet on April 17 to discuss a deal to freeze their output at January levels, though some analysts are skeptical that the producers will reach an agreement.

Mr. Andurand doesn’t think that such limits are needed.

“You have 3.5% of world oil supply that is forever below cash cost,” he said. “We see production declines already coming from a lot of countries—U.S. output is falling, but also China, Azerbaijan, Kazakhstan, Mexico….”

Mr. Andurand prefers to form such trading views in the silence of his own office—fitted with an ivory leather couch and floor-to-ceiling windows that look out onto luxury department store Harrods—by reading reams of analysis, rather than amid the chatter of peers. Guests enter the trading floor between two large fish tanks, designed to add a calming influence.

“I need to be really quiet,” he said. “In order to be an independent thinker, you should not speak to too many people.”

He also is the final decision maker on the fund. “I don’t need other people agreeing with the view,” he said, adding that the fund’s risk limits help protect against losses. “Sometimes it will be too late before everybody agrees.”

Mr. Andurand, 39 years old, was born in France but spent six years growing up on the small French island of Reunion off the coast of Madagascar, because his father, a civil servant who bought guidance equipment for planes, wanted to live somewhere with better weather.

Mr. Andurand began trading energy for Goldman Sachs Group Inc. in Singapore, when the oil price wasn’t far from today’s levels. He moved to Bank of America Corp. and then Vitol Group, the world’s biggest independent oil trader, which transferred him to London.

It was there that he branched out, co-founding BlueGold Capital with trader Dennis Crema. The fund began trading in February 2008, shortly before the financial crisis took hold. The fund made more than 30% in February alone and a staggering 209% that year, after betting against oil in the final four months of the year, as Lehman Brothers collapsed and oil plunged 60%. They then flipped the bet just as oil was starting a long recovery.

But the venture didn’t end well. BlueGold shut down in 2012 after losing more than one-third the previous year, including a 23% loss in May 2011 alone, as its bullish bets were hit by falling prices. Mr. Andurand said the closure was unrelated to the losses and instead due to his desire to part ways with his partner.

At the time, Mr. Andurand also veered off into investing in equities, a move questioned by some investors. This time around, the fund has stuck to trading oil.

FT : Allergan plunges 22% on new tax inversion curbs

Allergan plunges 22% on new tax inversion curbs
The Obama administration helped wipe more than $20bn off the market value of Allergan by revealing plans to deter tax avoidance that threaten the Dublin-based drugmaker’s proposed combination with US rival Pfizer.
Allergan’s share price fell more than 22 per cent in after-market trading on Monday on fears that the moves to halt tax-cutting deals, known as inversions, would scupper the company’s deal with Pfizer.

After two years of US companies stoking controversy with deals that shift their headquarters to countries with lower tax rates, the proposed moves marked Washington’s most aggressive effort to crack down on the trend.
Pfizer’s $160bn takeover of Allergan — due to be finalised in the second half of this year — is the biggest proposed inversion to date and its collapse would send shockwaves through Wall Street and Washington.
With Allergan shares tumbling following Monday’s announcement from the US Treasury, analysts at Evercore ISI wrote: “The deal is trading as if it’s 95 per cent dead.”
The potential killer blow appeared to be a Treasury proposal to alter the way the size of companies in mergers is calculated, which would probably affect Allergan and make it harder for its Pfizer deal to qualify as an inversion.
Inversions have drawn cross-party condemnation on the presidential campaign trail, from the Republican frontrunner Donald Trump to the likely Democratic nominee Hillary Clinton.
Bernie Sanders, Mrs Clinton’s Democratic rival, has called on President Barack Obama to block the Pfizer-Allergan deal.
To qualify as an inversion and gain the attendant tax benefits, a merger must result in the shareholders of the non-US company owning a minimum percentage of the new entity — usually 20 per cent.
The Treasury-proposed changes to the treatment of past combinations could make Allergan appear smaller, making it harder to reach the ownership threshold.
“Our initial read is that Treasury finally is trying to disrupt specific inversion transactions after two rounds of more general rule proposals in which they said they were not trying to do so,” said Terry Haines at Evercore ISI.
Jack Lew, Treasury secretary, said: “This will have an important effect, but we cannot stop these transactions without new legislation [from Congress].”

Allergan’s market capitalisation, which stood at nearly $110bn before the announcement, dropped below $90bn.
Pfizer said on Monday: “We are conducting a review of the US Department of Treasury’s actions announced today. Prior to completing the review, we won’t speculate on any potential impact.”
The latest moves, which came in the form of proposals that could be challenged in the courts by affected companies, were the Treasury’s third attempt in two years to deter inversion deals.
The Obama administration’s first efforts in 2014 focused on making it harder to secure one big benefit of inversions: low-tax access to earnings that US companies have parked offshore.
That helped scupper another pharmaceuticals deal, AbbVie’s planned £32bn takeover of UK-listed Shire. But dealmaking otherwise continued largely unabated, leaving the government looking somewhat toothless.
Another part of this week’s moves seeks to make it harder for inverted companies to use a separate technique called “earnings stripping” to profit from inversions.
This involves making loans from a foreign head office to a US subsidiary so that the interest payments can be deducted from US tax bills.
Mr Lew said the Treasury was “focusing on transactions that generate large interest deductions [on tax bills] by simply transferring debt between subsidiaries without financing new investment in the United States”.
Steve Rosenthal, senior fellow at the Tax Policy Center, a think-tank, praised the Treasury for making a “bold” move.
But Kevin Brady, the top Republican tax writer in the House of Representatives, said: “Instead of unveiling commonsense policies to help American employers compete globally and create new jobs for our workers, the Obama administration just announced punitive regulations that will make it even harder for American companies to compete.”
US executives doing inversions argue that an uncompetitive US tax code puts them at a disadvantage to foreign rivals and is forcing them to flee.
The US tax code has a headline corporate income tax rate of 35 per cent versus 12.5 per cent in Ireland and 20 per cent in the UK.
Equally importantly, the US taxes overseas profits when they are brought home — unlike many other countries — which has prompted a lot of companies to keep their cash stashed in foreign jurisdictions.
Company lobbyists in Washington said before the Treasury’s announcement that they did not think it would be able to come up with rules to halt the tide of inversions.

(GS) French Telcos : Deal failure, but positive pricing signals for growth; CL B



Deal failure, but positive pricing signals for growth; CL Buy ORAN

Adjusting valuation post ORAN & BOUY ending consolidation talks
Bouygues cited two key reasons for ending talks: deal execution risk and
governance concerns over its stake in Orange that would have come as
part payment. But given the €10-20 bn net value accretion for the French
market that we estimated could come from consolidation (see our note End
of M&A talks negative for market, April 4, 2016) we continue to see
ongoing material incentives for this deal. Given the end of talks, we lower
the expected probability of French consolidation reflected in our target
valuations to 20% (from 60%), which lowers our 12-month price targets.

Encouraging signs on pricing for market growth prospects
With concerns of near-term price aggression post the deal failure, we see
two recent inflationary price moves as supportive: Bouygues raised its
premium broadband price by c.20% and NUM raised prices up to 10%
across its fixed and mobile base, albeit with more content now included.
Long term, we expect market growth boosted by inflationary pricing given:
(1) France has the second-lowest pricing in Europe; (2) Bouygues is
structurally challenged as a scale mobile player struggling to build scale in
fixed – its 2015 CMD strategy is dependent on inflationary pricing; and (3)
both players will need material ARPU expansion as neither make any cash
from current operations.

Orange CL Buy - compellingly priced organic growth, 48% upside
Group sales have now grown for the second consecutive quarter following
six years of decline. French top-line trends are improving and will inflect to
growth during 2016, on our estimates, with price rises offering upside risk.
With ongoing cost-cutting, we model 2016-20E group sales/EBITDA CAGRs
of +1.5%/+4.1%. Orange trades on a 10% 2017E FCF yield, a 25% discount
to the sector despite a modestly superior growth outlook. With French
consolidation less likely our ROIC-based 12-month price target falls to
€21.5 (from €22.2), which includes an M&A component.

Other PT changes: Altice, NUM, ILD remain Buy; BOUY Neutral
We adjust our 12-month price targets for the other French operators,
reflecting the lower probability of consolidation (from 60% to 20%).